Lifeward Financial Results
Lifeward Ltd. reported Q3 2026 financial results, highlighted by an 18% year-over-year increase in AlterG revenue to $3.6 million. The company is transitioning its ReWalk exoskeleton business to a capital-efficient channel-partner distribution model, including a pilot program with Ottobock Care, to expand patient access and reduce operating expenses.
- Term
- Q3 2026
“Our third quarter results reflect the continued momentum of AlterG, which delivered its second consecutive quarter of double-digit year-over-year revenue growth. We are also making significant progress in our strategic transition of ReWalk to a channel-partner model, which we believe is the most effective way to scale this business and bring our life-changing technology to more patients.”
Larry Jasinski, Chief Executive Officer
“We remain focused on driving commercial execution and managing our resources effectively as we advance our transition to a channel-partner model for ReWalk. We believe this model will allow us to reach more patients while improving our operating efficiency and cash flow over the long term.”
Ronen Tsimerman, Chief Financial Officer